 Study hypotheses: 1 Flavocoxid has an acceptable safety and tolerability profile as determined by the Generally Regarded as Safe GRAS profile in patients with OA compared to identical placebo. 2 Flavocoxid will be more effective as a therapy for OA compared to identical placebo. 